Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0001209191-21-060952

Options or other derivatives

  • Chief Legal Officer acquired 192,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bair Teresa Brophy · Chief Legal Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-10-18 Grant or award : show line 1 in the form Option to purchase common stock +192,000 $17.51 2031-10-17 192,000 192,000 D
Loading xslF345X03/doc4.xml…